A Study of E6011 in Participants With Active Crohn's Disease

NCT03733314 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: E6011
DRUG: Placebo

Sponsor

EA Pharma Co., Ltd.